Status:

COMPLETED

Prospective Research in Memory Clinics (PRIME)

Lead Sponsor:

Janssen-Cilag Pty Ltd

Conditions:

Dementia

Mild Cognitive Impairment

Eligibility:

All Genders

Brief Summary

The purpose of the PRIME Study is to examine the current management and outcomes of patients with mild cognitive impairment or dementia. Approximately 4500 patients will be enrolled in this disease re...

Detailed Description

A complete record of patient care will be collected to provide detailed information on the management and outcome of mild cognitive impairment and dementia and the profile of patients at participating...

Eligibility Criteria

Inclusion

  • Diagnosis of dementia under the DSM-IV criteria, or of Mild Cognitive Impairment, using the Peterson Criteria
  • Living in the community (home, apartment or collective housing with nursing care available for less than 40 hours per week)
  • Patient able to provide written informed consent, or provision of written informed consent by a legal guardian/proxy
  • Availability of a caregiver willing to provide consent for required components of the study
  • Fluent in English
  • May be participating in a Phase IV or other post-marketing follow up study of an approved product for treatment of dementia

Exclusion

  • No concomitant life-threatening illness (a condition which is likely to interfere with the patient's ability to complete the study)
  • Not unwilling or unable to complete the study
  • Not concurrently participating in a clinical trial of an investigational drug (phase I, II or III)
  • Unwillingness of patient or legal guardian / proxy to provide written informed consent
  • Unwillingness of caregiver to provide written informed consent
  • For patients with diagnosis of mild cognitive impairment: current or previous treatment with any cholinesterase or memantine

Key Trial Info

Start Date :

August 1 2005

Trial Type :

OBSERVATIONAL

Allocation :

ACTUAL

End Date :

August 1 2011

Estimated Enrollment :

970 Patients enrolled

Trial Details

Trial ID

NCT00297271

Start Date

August 1 2005

End Date

August 1 2011

Last Update

December 2 2013

Active Locations (9)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 3 (9 locations)

1

Chermside, Australia

2

Fremantle, Australia

3

Geelong, Australia

4

Heidelberg, Australia